Figure 1.

Relative Expression of HIF1α and VEGF-A in 57 AML Patients and 17 Healthy Patients was Measured from Ct Values and Normalized against a Reference Gene (ABL). A) A significant difference (P < 0.0001) between HIF1α expression in AML patients and healthy patients were identified. A relative HIF1α expression level of 12.61 ± 3.25 (SD) was measured in AML patients in comparison to 2.46 ± 0.33 (SD) in the normal control group. B) A significant difference (P < 0.005) between VEGF-A expression in AML patients and healthy patients were also identified. A relative VEGF-A expression level of 5.04 ± 0.76 (SD) was measured in AML patients in comparison to 2.003 ± 0.24 (SD) in the normal control group